The race to substitute Medtronic’s Infuse bone growth product has a new contender in the form of a novel product made from a biomarker in the blood of black bears that allows them to hibernate for months without losing bone mass. Aursos Inc. is raising money and hoping to begin human studies in 2014 of […]
Something is stirring around Aursos, the sleepy biotech that uses proteins from black bears to develop an osteoporosis treatment. The Kalamazoo, Mich., company has raised $500,000 and may raise up to $1.3 million to start clinical trials.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.